Analysis Premier Biomedical Inc (BIEI)
6/1/2024
Analysis of Premier Biomedical Inc (BIEI)
Premier Biomedical Inc (BIEI) has shown some volatility in its stock price over the past few days. The stock closed at $0.00114 on May 31st, after opening at $0.00110. The Relative Strength Index (RSI) indicates that the stock is approaching oversold levels at 39.00415, suggesting a potential buying opportunity.The Moving Average Convergence Divergence (MACD) indicator is slightly negative at -0.00002, with the MACD line below the signal line. This could indicate a short-term bearish trend. However, the MACD histogram is decreasing, which might suggest a potential reversal in the near future.
The stock has been trading below its Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) over the past few days, indicating a bearish trend. The stock price has been fluctuating between $0.00100 and $0.00120, with the latest closing price at $0.00114.
Overall, Premier Biomedical Inc appears to be in a short-term bearish trend based on the technical indicators. Traders and investors should closely monitor the RSI, MACD, and moving averages for any signs of a trend reversal.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company indicate a moderate growth trend.For the current quarter ending on June 30, 2024, the average estimate is $77,545,400,000, with a sales growth of 2% compared to the same period last year. The number of analysts providing estimates is 25.
Looking at the next quarter ending on September 30, 2024, the average estimate increases to $85,501,800,000, with a sales growth of 3% compared to the previous year. The number of analysts remains at 25.
For the current fiscal year ending on September 30, 2024, the average estimate for total sales is $357,772,000,000, showing a 1% growth compared to the previous year. The number of analysts providing estimates increases to 38.
In the following fiscal year ending on September 30, 2025, the average sales estimate rises to $380,772,000,000, indicating a more significant growth of 6% compared to the current fiscal year. The number of analysts remains at 38.
Overall, the estimates suggest a steady growth trajectory for the company's sales in the upcoming quarters and years, with a slightly increasing number of analysts providing forecasts.
Growth estimates
Based on the consensus estimates provided by analysts, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.1%.
2. Next Quarter: The estimated growth rate for the next quarter is slightly higher at 5.2%.
3. Current Year: For the current year, the estimated growth rate is 7.6%.
4. Next Year: The growth rate is expected to increase to 9.7% for the next year.
5. Past 5 Years: Over the past 5 years, the company has experienced an average annual growth rate of 20.15%.
6. Next 5 Years: Looking ahead, analysts project an average annual growth rate of 9.72% for the next 5 years.
These estimates suggest a positive outlook for the company's growth, with a gradual increase in the growth rate over the coming years compared to the past performance.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating that there is potential upside according to the analysts' predictions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous results, ending on February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at this time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.Financials:
- Cash flow: Operating cash flow TTM is $110,563,000,320 and levered free cash flow TTM is $84,726,874,112.
- Balance sheet: Total cash MRQ is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- Profit margin: 26.306%
- Fiscal year ends: September 30, 2023
- Income statement: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.43, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth YoY is -2.2%.
- Operating margin: 30.743%
- Most recent quarter: March 31, 2024
- Return on assets TTM: 22.073999%
- Return on equity TTM: 147.25%
Stock statistics:
- Short ratio: 1.53
- Float shares: 15,308,320,742
- Shares short: 99,287,450
- Average 10-day volume: 46,860,048
- Average 90-day volume: 57,498,254
- Shares outstanding: 15,334,099,968
- Percent held by insiders: 5.22%
- Percent held by institutions: 57.589%
- Short percent of shares outstanding: 0.65%
Valuation metrics:
- PEG ratio: 26.319502
- Forward PE: 26.319502
- Trailing PE: 29.59409
- Enterprise value: $2,950,762,332,160
- Price to book MRQ: 39.3405
- Price to sales TTM: 7.646095
- Enterprise to EBITDA: 22.763
- Enterprise to revenue: 7.732
- Market capitalization: $2,917,925,650,432
Stock price summary:
- Beta: 1.264
- 50-day moving average: $176.2646
- 200-day moving average: $181.0429
- 52-week low: $164.08
- 52-week high: $199.62
- 52-week change: 6.853%
Dividends and splits:
- Payout ratio: 14.93%
- Dividend date: May 16, 2024
- Last split date: August 31, 2020
- Ex-dividend date: May 10, 2024
- Last split factor: 4-for-1 split
- Forward annual dividend rate: $1
- 5-year average dividend yield: 0.73%
- Forward annual dividend yield: 0.5255%
- Trailing annual dividend rate: $0.97
- Trailing annual dividend yield: 0.5097%
Income statement 💸
These are the revenues. Draw conclusions.Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2018 at $107,147,000,000.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show significant variations, with large amounts being spent on common stock repurchase and debt issuance.
6. Investing activities also vary, with significant amounts being spent on the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, but there are fluctuations in different areas that may require further analysis.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. For the current quarter ending on June 30, 2024:
- Average Estimate: $1.23
- Low Estimate: $1.18
- High Estimate: $1.26
- Number of Analysts: 27
- Year Ago EPS: $1.17
2. For the next quarter ending on September 30, 2024:
- Average Estimate: $1.42
- Low Estimate: $1.33
- High Estimate: $1.51
- Number of Analysts: 26
- Year Ago EPS: $1.35
3. For the current year ending on September 30, 2024:
- Average Estimate: $6.10
- Low Estimate: $5.95
- High Estimate: $6.41
- Number of Analysts: 40
- Year Ago EPS: $5.67
4. For the next year ending on September 30, 2025:
- Average Estimate: $6.69
- Low Estimate: $5.92
- High Estimate: $7.31
- Number of Analysts: 40
- Year Ago EPS: $6.10
Based on these estimates, we can see a generally positive trend in the expected earnings per share for both the upcoming quarters and the next two fiscal years. It indicates growth in earnings compared to the previous year, with higher average estimates for each period.
MACD of BIEI
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
